ClinicalTrials.Veeva

Menu

Biograph Vision 600 Versus Biograph Vision.X PET/CT

V

Valentina Garibotto

Status

Enrolling

Conditions

Alzheimer Disease
Cancer

Treatments

Device: Images

Study type

Interventional

Funder types

Other

Identifiers

NCT07006155
2025-D00005

Details and patient eligibility

About

The main purpose is to evaluate initial clinical experiences and to explore whether the Vision.X system yields improved image quality and diagnostic performance compared to Vision 600.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Written Inform Consent to participating.
  • 18 to 85 years of age
  • Willing and able to comply with the requirements of the study, as judged by the investigator

Exclusion criteria

  • Women in pregnancy
  • Patients unable to lie still for the duration of the examination

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

40 participants in 2 patient groups

Vision X
Experimental group
Description:
PET/CT images acquired with Vision.X
Treatment:
Device: Images
Vision 600
Active Comparator group
Description:
PET/CT images in Vision 600
Treatment:
Device: Images

Trial contacts and locations

1

Loading...

Central trial contact

Pr Valentina Garibotto Head of the Division of nuclear medicine and molecular imaging, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems